Viatris (VTRS) Total Current Liabilities (2019 - 2026)

Viatris' (VTRS) quarterly Total Current Liabilities came in at $6.8 billion in Q1 2026, up 19.06% year-on-year from $5.7 billion in Q1 2025, and down 4.0% quarter-over-quarter from $7.1 billion in Q4 2025.

Viatris (VTRS) Total Current Liabilities (2019 - 2026) Analysis & Trends

Viatris' Total Current Liabilities history runs 8 years deep, the most recent figure standing at $6.8 billion for Q1 2026.

  • On a quarterly basis, Total Current Liabilities rose 19.06% year-over-year to $6.8 billion in Q1 2026; TTM through Mar 2026 was $6.8 billion, a 19.06% increase from a year earlier, with the FY2025 full-year figure at $7.1 billion, up 22.75% from the prior year.
  • Total Current Liabilities eased to $6.8 billion in Q1 2026 per VTRS's latest filing, from $7.1 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $9.6 billion in Q1 2022 and bottomed at $5.7 billion in Q1 2025.
  • The 5-year median for Total Current Liabilities is $7.1 billion (2025), against an average of $7.1 billion.
  • Across the five-year window, Total Current Liabilities tumbled 36.66% in 2023 and advanced 27.04% in 2024, its largest moves.
  • Year by year, Total Current Liabilities stood at $6.7 billion in 2022, then rose by 15.29% to $7.8 billion in 2023, then retreated by 25.69% to $5.8 billion in 2024, then grew by 22.75% to $7.1 billion in 2025, then fell by 4.0% to $6.8 billion in 2026.
  • Per Business Quant, the three latest VTRS Total Current Liabilities figures stand at $6.8 billion (Q1 2026), $7.1 billion (Q4 2025), and $7.4 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 215.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.81 Bn
Dec 31, 2025 7.09 Bn
Sep 30, 2025 7.36 Bn
Jun 30, 2025 7.13 Bn
Mar 31, 2025 5.72 Bn
Dec 31, 2024 5.78 Bn
Sep 30, 2024 7.51 Bn
Jun 30, 2024 7.71 Bn
Mar 31, 2024 7.76 Bn
Dec 31, 2023 7.78 Bn
Sep 30, 2023 6.83 Bn
Jun 30, 2023 6.52 Bn
Mar 31, 2023 6.11 Bn
Dec 31, 2022 6.75 Bn
Sep 30, 2022 6.52 Bn
Jun 30, 2022 7.68 Bn
Mar 31, 2022 9.64 Bn
Dec 31, 2021 9.88 Bn
Sep 30, 2021 10.10 Bn
Jun 30, 2021 10.13 Bn